Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI North America CPhI North America
Not Confirmed
Not Confirmed
20-22 May, 2025
Not Confirmed
Not Confirmed
22-25 April, 2025
AACR Annual meetingAACR Annual meeting
Not Confirmed
Not Confirmed
25-30 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI North America CPhI North America
Industry Trade Show
Not Confirmed
20-22 May, 2025
Industry Trade Show
Not Confirmed
22-25 April, 2025
AACR Annual meetingAACR Annual meeting
Industry Trade Show
Not Confirmed
25-30 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/top-pharma-companies-drugs-in-2024-merck-s-keytruda-maintains-top-spot-as-novo-s-semaglutide-nips-at-its-heels
15 Apr 2024
// INDINPHARMAPOST
https://www.indianpharmapost.com/news/moderna-pauses-plan-to-build-mrna-manufacturing-facility-in-kenya-15526
31 May 2022
// CONTRACTPHARMA
https://www.contractpharma.com/contents/view_breaking-news/2022-05-31/croda-forms-new-pharma-business/?widget=listSection
06 Jul 2020
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/avanti-polar-lipids-agrees-to-be-acquired-by-croda-301088330.html
Details:
The contract with Pfizer runs for five years and awards Croda an initial supply contract for four component excipients used in the production of the vaccine candidate (BNT162b2) for the first three years of the contract. Demand remains subject to relevant approvals.
Lead Product(s): COVID-19 Vaccine
Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Vaccine
Sponsor: Pfizer Inc
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement October 11, 2020
Lead Product(s) : COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Pfizer Inc
Deal Size : Undisclosed
Deal Type : Agreement
Croda Strikes Deal with Pfizer to Supply COVID-19 Vaccine Additives
Details : The contract with Pfizer runs for five years and awards Croda an initial supply contract for four component excipients used in the production of the vaccine candidate (BNT162b2) for the first three years of the contract. Demand remains subject to relevan...
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
October 11, 2020
Excipients
ABOUT THIS PAGE